Medical Marijuana Market, By Types (Migraine, Arthritis, Cancer, Chronic and Pain) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
99 Pages | Published Date : 01 / 11 / 17 | Report Code: AV117 | Report Format: PDF
The medical marijuana market is estimated to represent a global market of USD 12.48 billion by 2016 with growth rate of 18.3%.
According to the National Institute on Drug Abuse (NIDA), Marijuana (also referred as cannabis) is the dried leaves of female flowers of hemp plant which contain psychoactive properties. Delta- 9- tetrahydrocannabinol (Delta-9-THC) is the important psychoactive ingredient, the most abundant cannabinoid presents in marijuana. The movement to accept cannabis as a medicine is propel by multiple factors, including inadequate relief of current available treatment approaches for number of chronic disease conditions such as Crohn’s disease, multiple Sclerosis, cancer, Alzheimer’s disease, and chronic pain. Such conditions are frequently cited by the proponents of marijuana i.e. cannabis for medical use. The market for medical marijuana is primarily driven by the growing application of marijuana in mentioned medical conditions.
Furthermore, large number of companies are increasingly investing in this market to capture significant revenue share. For example, Australia based MMJ PhytoTech Limited is considered to be the pioneer in the development of medical cannabis for international market, under regulated medical cannabis laws. The company is the first medical grade cannabis (MGC) company to list on the ASX. PhytoTech is primarily focused on the research and development activities on MGC therapeutics to be used in various medical applications. The company is aimed to become a leader in commercialization of cannabinoids based therapeutic products. Such initiatives would in turn help this market to establish healthy platform, hence drives the market growth. However, low penetration of marijuana for medical application in some developed as well as developing countries hamper the market growth.
The market is categorized as Migraine, Arthritis, Cancer, Chronic Pain, and Others. Chronic pain segment achieved largest share of the total medical marijuana market, captured 35.26% share of the market. The use of pain medication is rapidly increasing, imposing a major burden on the healthcare system. The use of medical marijuana is reported to significantly alleviate pain symptoms. Its application in cancer and arthritis is also considered to be growing in near future due to advancements and increasing awareness among patient population.
Regionally, developed countries of North America and Europe is the big market for medical marijuana. In Europe, medical cannabis is imported from Holland to the European countries such as Czech Republic, Croatia, Switzerland, Italy, Netherland, and others. Increasing number of prescriptions for the cannabis for various medical indication have surged the demand for medical marijuana in developed regions which will drive the market growth. For example, according to the Marijuana Business Fact Book (2014), more than 730,000 patients have received medical recommendation to use cannabis for different medical indication. Similarly, Health Canada, official forecast projected that medical cannabis patients will grow to 1.2% of the total Canadian population in next 10 years. This industry is predicated to grow at 25% to 28% (i.e. more than 400,000 patients) patient growth by 2024. Huge demand coupled with necessity to include cannabis for medical application will support the market growth.
Owing to its huge benefits in medical application, the market is predicted to grow at slow but steady growth rate in developing regions. Government of some developing regions are considering marijuana as a potential economic opportunity. For example, Agriculture Minister of the Israeli government is researching to develop best ways to grow cannabis. The Health Ministry, having its own medical cannabis department is planning to extend the various licenses to support cannabis industry in the country. Such types of initiatives would in turn support the market growth to great extent during the forecast period.
Key Vendor Takeaway
Companies such as Cannabis Sativa, Cara Therapeutics, Lexaria Corp, United Cannabis Corporation, CannaGrow Holdings Inc., International Consolidated Companies, Inc. and others are present in this market. These companies are investing huge amount of their revenue share on research and development activities to develop novel marijuana based therapeutics for medical applications.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
- Historical Year – 2014 & 2015
- Base Year – 2015
- Estimated Year – 2016
- Projected Year – 2025
- Traders, Distributors, And Suppliers
- Government and Regional Agencies and Research Organizations
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TYPES
- Chronic Pain
MARKET, BY REGION
- North America
- Asia Pacific
- Rest of the World
MARKET, BY COUNTRY
- Further Breakdown of The North America Market
- Further Breakdown of The Europe Market
- Rest of Europe
- Further Breakdown of The APAC Market
- Rest of APAC
- Further Breakdown of The Rest of the World Market
- Middle East and Africa
- Latin America
1. MEDICAL MARIJUANA MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. MEDICAL MARIJUANA KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. MEDICAL MARIJUANA INDUSTRY STUDY
4.1. Regulatory Framework Analysis
4.2. Pipeline Analysis
4.3. Value Chain Analysis
5. MEDICAL MARIJUANA MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. MEDICAL MARIJUANA MARKET – BY TYPES:
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.5. Chronic Pain
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. MEDICAL MARIJUANA MARKET– BY GEOGRAPHY
7.2. North America
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
188.8.131.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
184.108.40.206. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
126.96.36.199. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
188.8.131.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.8. Rest of Europe
184.108.40.206. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Asia Pacific (APAC)
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.5. Rest of APAC
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Rest of the World
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.3. Latin America
126.96.36.199. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.4. Middle East and Africa
188.8.131.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. KEY VENDOR ANALYSIS
8.1. Cannabis Sativa
8.1.1. Company Overview
8.1.2. Product Benchmarking
8.1.3. SWOT Analysis
8.1.4. Key Developments
8.2. Cara Therapeutics
8.2.1. Company Overview
8.2.2. Product Benchmarking
8.2.3. SWOT Analysis
8.2.4. Key Developments
8.3. Lexaria Corp
8.3.1. Company Overview
8.3.2. Product Benchmarking
8.3.3. SWOT Analysis
8.3.4. Key Developments
8.4. United Cannabis Corporation
8.4.1. Company Overview
8.4.2. Product Benchmarking
8.4.3. SWOT Analysis
8.4.4. Key Developments
8.5. CannaGrow Holdings Inc.
8.5.1. Company Overview
8.5.2. Product Benchmarking
8.5.3. SWOT Analysis
8.5.4. Key Developments
8.6. International Consolidated Companies, Inc.
8.6.1. Company Overview
8.6.2. Product Benchmarking
8.6.3. SWOT Analysis
8.6.4. Key Developments
9. 360 DEGREE ANALYSTVIEW
10.1. Research Methodology
10.4. Contact Us
SCOPE AND OBJECTIVES :
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT :
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow
AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:
- Official Company’s Website, Financial and Annual Reporting
- Government Statistical Data
- Online Publishing Articles
- Industry Player’s Investor Presentations
- Economic News Articles
- National and International Trade Associations
- The Financial, Business and Mainstream Press
- Industry Study Groups and Other Semi-Official Sources
- Many Other Informative Channels Related to the Market Topics
Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide
In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.
Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.
Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.
We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.
Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
Data Accuracy and Reliability
We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.
We offer most competitive pricing policy across the research industry
Why Choose Us
We devise research report with quality data:
Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.
We work with businesses just like yours:
AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.